This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: D Grant Mcfadden: Innovator in Antirestenosis Treatment
Introduction
D Grant Mcfadden is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of medical treatments, particularly in addressing atheromatous plaque development. His innovative approach focuses on utilizing specific proteins to enhance therapeutic outcomes.
Latest Patents
Although D Grant Mcfadden currently holds no patents, he has developed a method known as the Antirestenosis Protein. This method involves administering an effective amount of SERP-I, mixed in a pharmaceutically acceptable carrier, to the intimal or lumenal layer of arterial walls. The method aims to treat both primary and recurrent atheromatous plaque development. Additionally, biologically active SERP-I analogs are also part of his research.
Career Highlights
D Grant Mcfadden is associated with Viron Therapeutics, Inc., where he works on advancing medical treatments. His expertise in the field has positioned him as a valuable asset to the company. His work focuses on innovative solutions to complex medical challenges.
Collaborations
D Grant Mcfadden collaborates with Alexandra Lucas, contributing to the development of new therapeutic methods. Their combined efforts aim to enhance the effectiveness of treatments for patients suffering from arterial plaque issues.
Conclusion
D Grant Mcfadden's work in the field of antirestenosis treatment showcases his commitment to innovation in medical science. His research and collaboration with others highlight the importance of teamwork in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile